Migraine’s Impact on Hearing and Sensory Health

Migraine affects over 1 billion people worldwide, ranking as the second leading cause of global disability. For patients with tinnitus, misophonia, or hyperacusis, this neurological disorder is far more than just a headache; it represents a significant comorbid condition with shared mechanisms of sensory processing dysfunction. A 2026 evidence review by Pola Kobryń, Igor Nowiński, and Dawid Ocicki consolidates the modern understanding of migraine as a complex brain network disorder, shifting away from outdated vascular models.

From Vascular Theory to Brain Network Disorder

The review authors detail a fundamental shift in migraine science. The historical view of migraine as primarily a problem of blood vessel constriction and dilation has been replaced. Current evidence frames migraine as a disorder of abnormal sensory processing and widespread neural network dysfunction.

This model centers on the activation of the trigeminovascular system—a pathway linking brain blood vessels, the trigeminal nerve, and pain centers. A critical player is calcitonin gene-related peptide (CGRP), a neuropeptide that drives inflammation and pain transmission. For migraine with aura, the phenomenon of cortical spreading depression—a wave of altered brain activity followed by suppression—is a key electrical event. These processes lead to peripheral and central sensitization, where the nervous system becomes hyper-reactive to normal stimuli. This state of heightened excitability directly parallels mechanisms observed in hyperacusis and chronic tinnitus, suggesting a common neurological vulnerability.

Diagnosis and the Critical Role of Comorbidity Assessment

Migraine diagnosis remains clinical, relying on patient history and the International Classification of Headache Disorders (ICHD-3) criteria. The authors stress that a thorough evaluation must extend beyond headache symptoms. Migraine frequently coexists with conditions highly relevant to a hearing health audience.

These include psychiatric disorders (anxiety, depression), sleep disorders like insomnia, vestibular conditions, and cardiovascular issues. The link between migraine and auditory dysfunction is strong, with shared pathways of central sensitization potentially explaining why conditions like tinnitus and migraine often co-occur. This overlap is explored in our article on Migraine Links to Hearing Disorders and Tinnitus. Identifying these comorbidities is not just academic; it directly informs a more effective, holistic treatment strategy.

A Multi-Pronged Treatment Strategy

Kobryń, Nowiński, and Ocicki outline a treatment approach that is necessarily layered and individualized. It splits into acute and preventive strategies, integrated with non-pharmacological support.

Pharmacological Interventions

Acute therapies aim to stop attacks and include triptans, NSAIDs, and gepants. Preventive treatments, taken daily to reduce attack frequency and severity, include beta-blockers, anticonvulsants, antidepressants, and the newer monoclonal antibodies targeting the CGRP pathway. These anti-CGRP drugs represent a direct application of the modern pathophysiology model.

Non-Pharmacological and Lifestyle Foundations

The evidence review gives equal weight to behavioral and lifestyle interventions. Patient education, regular physical activity, consistent sleep regulation, and dietary management form the cornerstone of long-term control. Sleep regulation, in particular, is a non-negotiable pillar, as poor sleep can lower the threshold for migraine, tinnitus, and misophonia reactivity. The importance of dietary patterns in managing neurological sensory conditions is also highlighted in our review of Dietary Patterns for Ménière’s and Tinnitus.

Neuromodulation devices, which use electrical or magnetic stimulation to modulate brain activity, offer another non-drug option. This approach shares a therapeutic principle with emerging neuromodulation treatments for tinnitus and misophonia, such as Transcutaneous Vagus Nerve Stimulation for Misophonia Relief.

Implications for Hearing Health Patients and Clinicians

The practical implication of this research is clear: migraine management in patients with auditory sensitivities cannot be siloed. A patient presenting with tinnitus or hyperacusis should be screened for migraine symptoms, and vice versa. The presence of one condition should prompt investigation for the other, as their shared mechanism of central sensitization suggests they may fuel each other.

Effective care requires a multidisciplinary perspective. Treatment plans should integrate headache management with audiological and behavioral therapies. For instance, sound therapy for tinnitus must consider migraine triggers, and stress-reduction techniques for misophonia may also prevent migraine attacks. The authors conclude that viewing migraine as both a neurological disease and a public health challenge is essential for developing the comprehensive, patient-centered care these complex conditions demand.

Source: Kobryń P, Nowiński I, Ocicki D. Contemporary perspectives on migraine: epidemiology, pathophysiology, clinical classification, comorbidities, and treatment strategies. J Educ Health Sport. 2026;94:72978. DOI: 10.12775/jehs.2026.94.72978.